New study shows baseline impulsivity links to residual symptoms but not relapse, highlighting the need for individualized, clinician-guided decisions.
Giles W. Story, PhD
Advertisement
Giles W. Story, PhD, from the University College London
Articles by Giles W. Story, PhD
Delay discounting links to residual depression symptoms but does not predict relapse after stopping antidepressant treatment in patients with remitted MDD.
Although patients with remitted MDD showed greater impulsivity than controls, a study found no link between delay discounting and relapse risk after stopping antidepressants.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
How Dermatology PAs Can Master Rapid Diagnostic Recognition
2
STAT6, ITK Inhibitors, IL-31, & IL-18 Headline Burgeoning Pipeline in Atopic Dermatitis, with David Rosmarin, MD
3
Emerging Evidence in Atopic Dermatitis Management, With Harrison Nguyen, MD, MBA, MPH
4
Managing FCS: LPL-Targeted Therapy, Drug Rationalization, and Atherosclerosis Risk
5